Correction

First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis (vol 124, pg 1222, 2021)

BRITISH JOURNAL OF CANCER (2021)

卷 124, 期 10, 页码 1746-1746

DOI: 10.1038/s41416-021-01312-1

Oncology

Correction to the paper has been published.

A Correction to this paper has been published: https://doi.org/10.1038/s41416-021-01312-1

点击您的名字以认领此论文并将其添加到您的个人资料中。